Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 95Gastrointestinal 6Thoracic 4Gynecologic 4Breast 3Genitourinary 2Other 1Dermatologic 1CNS 1

Conditions

Urinary Bladder Neoplasms 20Carcinoma, Renal Cell 12Colorectal Neoplasms 10Kidney Neoplasms 8Ovarian Neoplasms 6Neoplasms 5Carcinoma, Transitional Cell 5Urethral Neoplasms 4Stomach Neoplasms 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Multiple Myeloma 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Urothelial Carcinoma of the Bladder 1

Interventions

pembrolizumab 50Nivolumab 21Docetaxel 11atezolizumab 7Ipilimumab 7avelumab 6Cyclophosphamide 6Paclitaxel 5Cetuximab 5Carboplatin 5fludarabine 4Radiotherapy 4Gemcitabine 4utomilumab 3spartalizumab 3lenvatinib 3durvalumab 3Trastuzumab 3Specimen Handling 3Interleukin-2 3Cisplatin 3Bevacizumab 3Albumin-Bound Paclitaxel 3zimberelimab 2tremelimumab 2tisotumab vedotin 2tislelizumab 2sargramostim 2obinutuzumab 2epacadostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Fluorouracil × Genitourinary × Clear all
NCT05891171 2026-03-31

ARC-25

Arcus Biosciences, Inc.

Phase 1 Active not recruiting
40 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT05007106 2025-08-14

KEYVIBE-005

Merck Sharp & Dohme LLC

Phase 2 Completed
613 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡